Can bosentan cause birth defects?

Can bosentan harm an unborn baby?

Bosentan is labeled Pregnancy Category X. Animal studies showed major craniofacial and cardiovascular malformations in offspring exposed during organogenesis. Human data are limited, but the drug is contraindicated in pregnancy because of this clear risk.

How is pregnancy managed while taking bosentan?

Women of childbearing potential must have a negative pregnancy test before starting therapy and monthly thereafter. Two reliable forms of contraception are required during treatment and for one month after stopping the drug. Any suspected pregnancy requires immediate discontinuation and medical evaluation.

Why do regulators require such strict controls?

Bosentan blocks endothelin receptors, a pathway essential for normal fetal vascular development. Blocking this pathway produces the same pattern of birth defects seen in animal models, prompting the FDA and EMA to impose enrollment in a restricted-distribution program (Tracleer REMS) that verifies compliance with pregnancy testing and contraception.

What happens if a woman becomes pregnant while on bosentan?

The drug must be stopped at once. The patient should be referred to a high-risk obstetrician for monitoring of fetal development. No antidote exists; management focuses on supportive care and serial ultrasounds to detect malformations.

Do alternatives exist for women who want to become pregnant?

Physicians may switch patients planning pregnancy to other pulmonary arterial hypertension therapies that lack teratogenic warnings, such as certain prostacyclin analogs or PDE-5 inhibitors. Choice depends on disease severity and requires cardiology input.

When does bosentan patent protection end?

U.S. patents covering bosentan expired in 2015; generic versions are now widely available. DrugPatentWatch.com tracks remaining method-of-use or formulation patents that could affect specific generic launches.